Evolución temporal en el tratamiento transcatéter de la estenosis aórticaanálisis del registro español de TAVI

  1. Pilar Jiménez-Quevedo 24
  2. A. J. Muñoz García 25
  3. R. Trillo Nouche 26
  4. Raquel del Valle Fernández 27
  5. José M. de la Torre Hernández 1
  6. Luisa Salido Tahoces 2
  7. Enrique Gutiérrez Ibañes 3
  8. Manuel Pan Álvarez-Osorio 4
  9. Joaquín Sánchez Gila 5
  10. Bruno García del Blanco 6
  11. Raúl Moreno Gómez 7
  12. Roberto Blanco Mata 8
  13. Juan F. Oteo Domínguez 9
  14. Ignacio Amat Santos 10
  15. Ander Regueiro 11
  16. Francisco Ten Morro 12
  17. Juan Manuel Nogales Asensio 13
  18. Eduard Fernández-Nofrerías 14
  19. Leire Andraka Ikazuriaga 15
  20. María Cruz Ferrer García 16
  21. Eduardo Pinar Bermúdez 17
  22. Rafael Romaguera Torres 18
  23. Carlos Cuellas Ramón 19
  24. Fernando Alfonso 20
  25. Sergio García Blas 21
  26. Antonio Piñero Lozano 22
  27. Julia Ignasi 24
  28. Rocío Díaz Méndez 23
  29. Pascual Bordes 26
  30. Juan Meseguer 26
  31. L. Nombela Franco 24
  32. Show all authors +
  1. 1 Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, España
  2. 2 Servicio de Cardiología, Hospital Ramón y Cajal, Madrid, España
  3. 3 Servicio de Cardiología, Hospital Gregorio Marañón, CIBERCV, Universidad Carlos III, Madrid, España
  4. 4 Servicio de Cardiología, Hospital Universitario Reina Sofía, Universidad de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, España
  5. 5 Servicio de Cardiología, Hospital Universitario Virgen de las Nieves, Granada, España
  6. 6 Servicio de Cardiología, Hospital Universitari Vall d’Hebron, Barcelona, España
  7. 7 Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España
  8. 8 Servicio de Cardiología, Hospital General Universitario de Valencia, Valencia, España
  9. 9 Servicio de Cardiología, Hospital Puerta de Hierro, Majadahonda, Madrid, España
  10. 10 Servicio de Cardiología, Hospital Clínico Universitario de Valladolid, Valladolid, España
  11. 11 Servicio de Cardiología, Hospital Clínic, Barcelona, España
  12. 12 Servicio de Cardiología, Hospital Universitario y Politécnico La Fe, Valencia, España
  13. 13 Servicio de Cardiología, Hospital Universitario de Badajoz, Badajoz, España
  14. 14 Servicio de Cardiología, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
  15. 15 Servicio de Cardiología, Hospital Universitario de Basurto, Bilbao, Bizkaia, España
  16. 16 Servicio de Cardiología, Hospital Universitario Miguel Servet, Zaragoza, España
  17. 17 Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, España
  18. 18 Servicio de Cardiología, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, España
  19. 19 Servicio de Cardiología, Hospital Universitario de León, León, España
  20. 20 Servicio de Cardiología, Hospital Universitario de La Princesa, Madrid, España
  21. 21 Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, España
  22. 22 Servicio de Cardiología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España
  23. 23 Servicio de Cardiología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, España; Servicio de Cardiología, Hospital Universitario Virgen de la Victoria, Málaga, España
  24. 24 Servicio de Cardiología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, España
  25. 25 Servicio de Cardiología, Hospital Universitario Virgen de la Victoria, Málaga, España
  26. 26 Servicio de Cardiología, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, España
  27. 27 Servicio de Cardiología, Hospital Central de Asturias, Oviedo, Asturias, España
Show affiliations +
Journal:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Year of publication: 2020

Volume: 2

Issue: 2

Pages: 96-105

Type: Article

DOI: 10.24875/RECIC.M19000087 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: REC: Interventional Cardiology

Abstract

Introduction and objectives: This study primary endpoint was to present the in-hospital all-cause mortality of the Spanish TAVI registry from its inception until 2018. Secondary endpoints included other in-hospital clinical events, 30-day all-cause mortality, and an assessment of the time trend of this registry. Methods: All consecutive patients included in the Spanish TAVI registry were analyzed. In this time-based analysis, the population was been divided into patients treated before 2014 (cohort A: 2009-2013) and patients treated between 2014 and 2018 (cohort B). Results: From August 2007 to June 2018, 7180 patients were included. The mean age was 81.2 ± 6.5 years and 53% were women. The logistic EuroSCORE was 12% (8-20). Transfemoral access was used in 89%. In-hospital and 30-day all-cause mortality was 4.7% and 5.7%, respectively. On the time-based analyses during the hospital stay, the rate of myocardial infarction, stroke, need for pacemakers, tamponade, coronary obstruction, and vascular complications was similar between both groups. However, cohort B showed less need for conversion to surgery and malapposition of the valve. Also, the implant success rate increased from 93% to 96% (P < .001). In-hospital and 30-day all-cause mortality was significantly lower in cohort B, ([OR, 0.65; IC95%, 0.48-0.86; P = .003] and [OR, 0.71; IC95%, 0.54-0.92; P = .002], respectively). Conclusions: The time trend analysis of the Spanish TAVI registry showed a change in the patients’ clinical profile and an improvement in the in-hospital clinical outcomes and 30-day all-cause mortality in patients treated more recently.

Bibliographic References

  • 1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
  • 2. Thyregod HG, Steinbrüchel DA, I hlemann N, et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis:1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015;65:2184-2194.
  • 3. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704.
  • 4. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients:a propensity score analysis. Lancet. 2016;387:2218-2225.
  • 5. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
  • 6. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
  • 7. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609-1620.
  • 8. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-1798.
  • 9. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972-1981.
  • 10. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic- Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376:1321-1331.
  • 11. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380:1695-1705.
  • 12. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019;380:1706-1715.
  • 13. Islas F, Almería C, García-Fernández E, et al. Usefulness of echocardiographic criteria for transcatheter aortic valve implantation without balloon predilation:a single-center experience. J Am Soc Echocardiogr. 2015;28:423-429.
  • 14. García E, Almería C, UnzuéL, Jiménez-Quevedo P, Cuadrado A, Macaya C. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty:role of 2D/3D transesophageal echocardiography. Catheter Cardiovasc Interv. 2014;84:868-876.
  • 15. Auffret V, Lefevre T, Van Belle E, et al. Temporal Trends in Transcatheter Aortic Valve Replacement in France:FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol. 2017;70:42-55.
  • 16. Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom:temporal trends, predictors of outcome, and 6-year follow-up:a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation. 2015;131:1181-1190.
  • 17. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials:a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-217.
  • 18. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation:the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33:2403-2418.
  • 19. SabatéM, Cánovas S, García E, et al. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation:data from the TAVI National Registry 2010-2011. Rev Esp Cardiol. 2013;66:949-958.
Data source: Dialnet